Early reproductive loss and COVID-19: realities and prospects

• Marina B. Khamoshina
• Annagul Ismailova
• Fatima Y. Ramazanova
• Sergey I. Kyrtikov
• Khalid Haddad

AbstractThe pandemic of COVID-19 has entailed sudden and very significant changes in the conditions, lifestyle and health status of the vast majority of the population. Global prerequisites have been formed for a significant decrease in the reproductive potential and quality of life of women of fertile age, primarily due to the growth of gynecological diseases, in the pathogenesis of which play a role chronic stress, drug load on the body and coagulation disorders, as well as due to an increase in the frequency of pregnancy both unplanned and desired that does not lead to childbirth. The data of domestic and foreign studies of recent years on early reproductive losses, which indicate that the SARS-CoV-2 infection and its consequences can serve as a pathogenetic con-founder, contributing to an increase in the risk of miscarriage and non-developing pregnancy.

Keywords:COVID-19, SARS-CoV-2; miscarriage; abortion; pregnancy loss; non-developing pregnancy; women's reproductive health

REFERENCES

1. Radzinsky V.E., Khamoshina M.B. Unsolved problems of modern gynecology: Quo vadis? Doctor.Ru. 2016; 7 (124): 4-9. (in Russian)

2. Prevention, diagnosis and treatment of new coronavirus infection (COVID-19). Temporary Methodological recommendations of the Ministry of Health of the Russian Federation. Version 13 (14.10.2021). 2021: 6. (in Russian)

3. Yunusova D.Z. Maternal losses during the COVID-19 pandemic in Tajikistan. In: Ott Readings: Abstracts III All-Russian Scientific and Practical Conferences for Obstetricians and Gynecologists (12-13 November 2021, St Petersburg). Moscow: Izdatel’stvo zhurnala StatusPraesens, 2021: 36. (in Russian)

4. World Health Organization (WHO) Weekly Operational Update on COVID-19 // Emergency Situational Updates. 2021. Vol. 77. P. 1-10.

5. Belokrinitskaya T.E., et al. Clinical course, maternal and neonatal outcomes of COVID-19 infection in pregnancy: an epidemiological study in Siberia and the Far East. Gynecology. 2021; 23 (1): 43-7.

6. Sacinti K.G., et al. Increased incidence of first-trimester miscarriage during the COVID-19 pandemic. Ultrasound Obstet Gynecol. 2021; 57 (6): 1013-4.

7. Methodological recommendations of the Ministry of Health of the Russian Federation «Organization of medical care for pregnant women, women in labor, maternity women and newborns with a new coranovirus infection COVID-19». 2021. Version 4: 6. (in Russian)

8. RANZCOG. COVID-19 Vaccination in Pregnant and Breastfeeding Women. Updated Wednesday 10 March 2021. URL: https://ranzcog.edu.au/statementsguide-lines/covid-19-statement/covid-19-vaccination-information

9. URL: https://www.cdc.gov/coronavirus/2019-ncov/vaccines/effectiveness.html

10. States U. When will the COVID-19 pandemic end? March 2021 Update.

11. Khamoshina M.B., Demina O.A., Ismailova A., Artemenko Y.S., Ramaza-nova F.U. Abstracts of the III All-Russian Scientific and Practical Conference for obstetrician-gynecologists "Otto Readings" (November 12-13, 2021, St. Petersburg). Moscow: Publishing House of Status Praesens, 2021. 32 p. (in Russian)

12. Diamond-Smith N., et al. COVID-19’s impact on contraception experiences: exacerbation of structural inequities in women’s health. Contraception. 2021; 104 (6): 600-5.

13. Carneiro Gomes P.R., et al. Alterations of the male and female reproductive systems induced by COVID-19. Wien Klin Wochenschr. 2021; 133 (17-18): 966-72.

14. Sharma I., et al. SARS-CoV-2 and the reproductive system: known and the unknown..!! Middle East Fertil Soc J. 2021; 26 (1): 1.

15. Hoffmann M., et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181 (2): 271-80.e8.

16. Wang M.Y., et al. SARS-CoV-2: structure, biology, and structure-based therapeutics development. Front Cell Infect Microbiol. 2020; 10: 587269.

17. Dong M., et al. ACE2, TMPRSS2 distribution and extrapulmonary organ injury in patients with COVID-19. Biomed Pharmacother. 2020; 131: 110678.

18. Cui D., et al. Single-cell RNA expression profiling of SARS-CoV-2-related ACE2 and TMPRSS2 in human trophectoderm and placenta. Ultrasound Obstet Gynecol. 2021; 57 (2): 248-56.

19. Weatherbee B.A.T., Glover D.M., Zernicka-Goetz M. Expression of SARS-CoV-2 receptor ACE2 and the protease TMPRSS2 suggests susceptibility of the human embryo in the first trimester. Open Biol. 2020; 10 (8): 200162.

20. Liu H., et al. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company’s public news and information website. 2020. January.

21. Zambrano L.D., et al. Update: characteristics of symptomatic women of reproductive age with laboratory-confirmed SARS-CoV-2 infection by pregnancy status -United States, January 22-October 3, 2020. MMWR Morb Mortal Wkly Rep. 2020; 69 (44): 1641-7.

22. Collin J., et al. Public Health Agency of Sweden’s Brief Report. Pregnant and postpartum women with severe acute respiratory syndrome coronavirus 2 infection in intensive care in Sweden. Acta Obstet Gynecol Scand. 2020; 99 (7): 819-22.

23. Narang K., et al. SARS-CoV-2 Infection and COVID-19 during pregnancy: a multidisciplinary review. Mayo Clin Proc. 2020; 95 (8): 1750-65.

24. Bloise E., et al. Expression of severe acute respiratory syndrome coronavirus 2 cell entry genes, angiotensin-converting enzyme 2 and transmembrane protease serine 2, in the placenta across gestation and at the maternal-fetal interface in pregnancies complicated by preterm. Am J Obstet Gynecol. 2021; 224 (3): 298.e1-8.

25. Sills E.S., Wood S.H. An experimental model for peri-conceptual COVID-19 pregnancy loss and proposed interventions to optimize outcomes. Int J Mol Cell Med. 2020; 9 (3): 180-7.

26. Tishkova O.G., Dikareva L.V. The role of the growth factor of differentiation (CDF-15) in the genesis of miscarriage. In: Ott Readings: Abstracts III All-Russian Scientific and Practical Conferences for Obstetricians and Gynecologists (12-13 November 2021, St Petersburg). - Moscow: Izdatel’stvo zhurnala StatusPraesens, 2021: 30-1. (in Russian)

27. Sharps M.C., et al. A structured review of placental morphology and histopathological lesions associated with SARS-CoV-2 infection. Placenta. 2020; 101: 13-29.

28. Baergen R.N., Heller D.S. Placental pathology in COVID-19 positive mothers: preliminary findings. Pediatr Dev Pathol. 2020; 23 (3): 177-80.

29. Markelova E.V., Tulupova M.S., Khamoshina M.B., Chepurnova N.S., Nevezhkina T.A. The role of the male factor in miscarriage. Problemy reproduktsii [Problems of Reproduction]. 2020; 26 (4): 85-90. (in Russian)

30. Agnaeva A.O. Assessment of the role of NK cells in the pathogenesis of multiple early reproductive losses: Diss. Saint Petersburg, 2019: 24 p. (in Russian)

31. Miscarriage (spontaneous abortion). Clinical guidelines of the Ministry of Health of the Russian Federation. 2021. URL: https://cr.minzdrav.gov.ru/recomend/670_1 (in Russian)

32. Favre G., et al. 2019-nCoV epidemic: what about pregnancies? Lancet. 2020; 395 (10 224): e40.

33. Yan J., et al. Coronavirus disease 2019 in pregnant women: a report based on 116 cases. Am J Obstet Gynecol. 2020; 223 (1): 111.e1-14.

34. Chen L., et al. Clinical characteristics of pregnant women with COVID-19 in Wuhan, China. N Engl J Med. 2020; 382 (25): e100.

35. Curi B., et al. Coronavirus infection in a high-risk obstetrical population of the South Bronx, New York. Am J Obstet Gynecol MFM. 2020; 2 (4): 100203.

36. D’Antonio F., et al. Maternal and perinatal outcomes in high compared to low risk pregnancies complicated by severe acute respiratory syndrome coronavirus 2 infection (phase 2): the World Association of Perinatal Medicine working group on coronavirus disease 2019. Am J Obstet Gynecol MFM. 2021; 3 (4): 100329.

37. Jing Y., et al. Potential influence of COVID-19/ACE2 on the female reproductive system. Mol Hum Reprod. 2020; 26 (6): 367-73.

38. Knight M., et al. Characteristics and outcomes of pregnant women admitted to hospital with confirmed SARS-CoV-2 infection in UK: national population based cohort study. BMJ. 2020; 369: m2107.

39. Shmakov R.G., et al. Clinical course of novel COVID-19 infection in pregnant women. J Matern Fetal Neonatal Med. 2020; Nov 29: 1-7.

40. Kazemi S.N., et al. COVID-19 and cause of pregnancy loss during the pandemic: A systematic review. PLoS One. 2021; 16 (8): e0255994.

41. Cavalcante M.B., et al. COVID-19 and miscarriage: from immunopathological mechanisms to actual clinical evidence. J Reprod Immunol. 2021; 148: 103382.

42. Pereira M., Dantas Damascena A., Galvao Azevedo L.M., de Almeida Oliveira T., da Mota Santana J. Vitamin D deficiency aggravates COVID-19: systematic review and meta-analysis. Crit Rev Food Sci Nutr. 2020; Nov 4: 1-9. DOI: https://doi.org/10.1080/10408398.2020.1841090

All articles in our journal are distributed under the Creative Commons Attribution 4.0 International License (CC BY 4.0 license)